SWOG clinical trial number
SWOG-8526
The Clinical Antitumor Activity of Recombinant Beta Interferon in Diffuse Mesothelioma
Closed
Phase
Published
Abbreviated Title
The Clinical Antitumor Activity of Recombinant Beta Interferon in Diffuse Mesothelioma
Activated
08/01/1986
Closed
07/15/1988
Publication Information Expand/Collapse
1990
Phase II evaluation of recombinant beta interferon (IFN-Bser) in patients with diffuse mesothelioma: A Southwest Oncology Group study.